Defence's Corporate Updates, Arranges Financing

newsfileSep 27 07:00 ET

Defence Appoints New Interim Chief Executive Officer

newsfileAug 30 20:00 ET

Defence Therapeutics Innovates in Diabetes and Obesity Treatment

TipRanksAug 19 10:07 ET

Defence Therapeutics Collaboration Agreement With Orano to Develop the Next Generation of Targeted Radio-Immunotherapy for Cancer Advances

newsfileAug 13 03:15 ET

Defence Receives No Objection Letter From Health Canada for Phase I Trial of Its ACCUM-002 (AccuTOX) as an Anti-Cancer Molecule in Patients With Melanoma

newsfileJul 8 03:15 ET

Defence's AccuTOX Boosts and Synergizes With Immune Checkpoint Inhibitors

newsfileJun 28 17:08 ET